Market Chatter: Panasonic Develops Automated iPS Cell System Aiming to Slash Treatment Costs to Under 1 Million Yen

MT Newswires Live04-21

Panasonic (TYO:6752) aims to bring the cost of producing induced pluripotent stem (iPS) cells below 1 million yen per patient using an automated culturing system it has developed, Nikkei Asia reported Tuesday, citing company official Yoshihiro Owaki.

The compact device, measuring 75 cm high, 70 cm wide, and 45 cm long, was unveiled at Osaka's CiRA Foundation research center on Monday, the publication said.

Currently, producing iPS cells costs approximately 50 million yen per patient, but Panasonic aims to bring that figure below 1 million yen, with field tests targeted for completion by March 2027 and commercialization planned for fiscal 2028, the news daily said.

Owaki added that the company sees iPS cell technology as a future growth area and intends to develop fully automated culture systems for other therapeutic cells, including immune cells, the report said.

Stem cells have the ability to grow into various tissues for medical use, with iPS cells specifically created by introducing genes into harvested adult cells to revert them to an embryonic-like state, it added.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2629086724?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-21 16:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629086724","market":"sh","top_or_hot":-1,"title":"Market Chatter: Panasonic Develops Automated iPS Cell System Aiming to Slash Treatment Costs to Under 1 Million Yen","media":"MT Newswires Live","content":"<html><body><p> Panasonic (TYO:6752) aims to bring the cost of producing induced pluripotent stem (iPS) cells below 1 million yen per patient using an automated culturing system it has developed, Nikkei Asia reported Tuesday, citing company official Yoshihiro Owaki.</p><p>The compact device, measuring 75 cm high, 70 cm wide, and 45 cm long, was unveiled at Osaka's CiRA Foundation research center on Monday, the publication said.</p><p>Currently, producing iPS cells costs approximately 50 million yen per patient, but Panasonic aims to bring that figure below 1 million yen, with field tests targeted for completion by March 2027 and commercialization planned for fiscal 2028, the news daily said.</p><p>Owaki added that the company sees iPS cell technology as a future growth area and intends to develop fully automated culture systems for other therapeutic cells, including immune cells, the report said.</p><p>Stem cells have the ability to grow into various tissues for medical use, with iPS cells specifically created by introducing genes into harvested adult cells to revert them to an embryonic-like state, it added.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Chatter: Panasonic Develops Automated iPS Cell System Aiming to Slash Treatment Costs to Under 1 Million Yen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Chatter: Panasonic Develops Automated iPS Cell System Aiming to Slash Treatment Costs to Under 1 Million Yen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-21 16:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Panasonic (TYO:6752) aims to bring the cost of producing induced pluripotent stem (iPS) cells below 1 million yen per patient using an automated culturing system it has developed, Nikkei Asia reported Tuesday, citing company official Yoshihiro Owaki.</p><p>The compact device, measuring 75 cm high, 70 cm wide, and 45 cm long, was unveiled at Osaka's CiRA Foundation research center on Monday, the publication said.</p><p>Currently, producing iPS cells costs approximately 50 million yen per patient, but Panasonic aims to bring that figure below 1 million yen, with field tests targeted for completion by March 2027 and commercialization planned for fiscal 2028, the news daily said.</p><p>Owaki added that the company sees iPS cell technology as a future growth area and intends to develop fully automated culture systems for other therapeutic cells, including immune cells, the report said.</p><p>Stem cells have the ability to grow into various tissues for medical use, with iPS cells specifically created by introducing genes into harvested adult cells to revert them to an embryonic-like state, it added.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4078","symbol_name":"消费电子产品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2629086724","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2629086724","pubTimestamp":1776760377,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Panasonic  aims to bring the cost of producing induced pluripotent stem  cells below 1 million yen per patient using an automated culturing system it has developed, Nikkei Asia reported Tuesday, citing company official Yoshihiro Owaki.The compact device, measuring 75 cm high, 70 cm wide, and 45 cm long, was unveiled at Osaka's CiRA Foundation research center on Monday, the publication said.Currently, producing iPS cells costs approximately 50 million yen per patient, but Panasonic aims to bring that figure below 1 million yen, with field tests targeted for completion by March 2027 and commercialization planned for fiscal 2028, the news daily said.Owaki added that the company sees iPS cell technology as a future growth area and intends to develop fully automated culture systems for other therapeutic cells, including immune cells, the report said.Stem cells have the ability to grow into various tissues for medical use, with iPS cells specifically created by introducing genes into harvest","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4078":"消费电子产品","PCRFY":"松下"},"translate_title":"市场热议：松下开发自动化iPS细胞系统旨在将治疗成本削减至100万日元以下","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRFY":1.5},"content_text":"Panasonic (TYO:6752) aims to bring the cost of producing induced pluripotent stem (iPS) cells below 1 million yen per patient using an automated culturing system it has developed, Nikkei Asia reported Tuesday, citing company official Yoshihiro Owaki.The compact device, measuring 75 cm high, 70 cm wide, and 45 cm long, was unveiled at Osaka's CiRA Foundation research center on Monday, the publication said.Currently, producing iPS cells costs approximately 50 million yen per patient, but Panasonic aims to bring that figure below 1 million yen, with field tests targeted for completion by March 2027 and commercialization planned for fiscal 2028, the news daily said.Owaki added that the company sees iPS cell technology as a future growth area and intends to develop fully automated culture systems for other therapeutic cells, including immune cells, the report said.Stem cells have the ability to grow into various tissues for medical use, with iPS cells specifically created by introducing genes into harvested adult cells to revert them to an embryonic-like state, it added.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2629086724","isCrawlerRequest":true}